Post Menopausal Women With Early Breast Cancer Clinical Trial
Official title:
Sequencing Of Endocrine Therapy In Post-Menopausal Women With Early Breast Cancer (FAST) a Non-interventional Trial With Aromasin®
Quality of life under therapy with Aromasin® (exemestane) according to IBCSG (International
Breast Cancer Study Group) questionnaire.
Change of the endometrium after switching from tamoxifen to Aromasin® (exemestane).
Deeper knowledge of Adverse Events during routine administration.
n/a
Observational Model: Case-Only, Time Perspective: Prospective